Literature DB >> 8220127

Magnetic resonance imaging in patients with bone marrow disorders.

W Negendank1, R L Soulen.   

Abstract

Magnetic resonance imaging (MRI) provides a non-invasive means to evaluate a large fraction of marrow in less than one hour. Marrow disorders produce non-specific changes in marrow signal intensities which primarily reflect changes in proportions of fat and cellular elements. The pattern of these signal changes narrows the differential diagnosis, and the combination of these features with the clinical context allows interpretations which are clinically useful in many ways. These include: 1) the diagnosis of avascular necrosis (and its distinction from other causes of joint pain), 2) detection of osteomyelitis, 3) differential diagnosis of hypoplastic disorders, 4) staging of lymphomas and myeloma, 5) selection of patients for autologous bone marrow transplant, 6) objective measures of marrow response to therapy, 7) detection of leukemic transformation, and 8) improved detection of marrow disease (primary or secondary) in patients with otherwise unexplained bone pain.

Entities:  

Mesh:

Year:  1993        PMID: 8220127     DOI: 10.3109/10428199309148551

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.

Authors:  Masami Iizuka-Mikami; Kiyohisa Nagai; Koji Yoshida; Takashi Sugihara; Yoshimasa Suetsugu; Makoto Mikami; Tsutomu Tamada; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2004-02-18       Impact factor: 5.315

2.  Clinical significance of magnetic resonance imaging of bone marrow in patients with leukemia.

Authors:  J Wang; X Zhang; J Niu
Journal:  J Tongji Med Univ       Date:  2001

Review 3.  MR imaging of therapy-induced changes of bone marrow.

Authors:  Heike E Daldrup-Link; Tobias Henning; Thomas M Link
Journal:  Eur Radiol       Date:  2006-09-21       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.